Borealis Biosciences
BC - VancouverBiotechnology
Focus: Borealis Biosciences is a Vancouver-based biotechnology company focused on RNA medicine for kidney disease, operating at Series A stage with a lean team of 1-50 employees.
Profile data last refreshed 15h ago · AI intelligence enriched 2w ago
Funding Stage
SERIES A
Employees
1-50
Open Jobs
1-1 this month
Stable — net -1 jobs in 30d
1 added, 2 removed. Backfill posture.
Should You Work at Borealis Biosciences?
AI assessmentBest suited for risk-tolerant scientists seeking equity upside and foundational impact in emerging RNA nephrology space; unsuitable for those prioritizing stability or career acceleration.
Why Work Here
- Early-stage opportunity to shape RNA medicine platform in high-need therapeutic area (nephrology) with limited competitive options
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Open Jobs (1)
Interview Prep Quick Facts
Open Roles: 1 active job
Hiring Trend
Help build intelligence for Borealis Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.